Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | KMO | O15229 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HMGCR | P04035 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28678912 | 0.86 | HMGCR (0.30) | HMGCR | |
| SCHEMBL29602464 | 0.85 | HMGCR (0.35) | PPARAPPARGTSHRDHODHHMGCR | |
| SCHEMBL28678911 | 0.85 | HMGCR (0.35) | PPARAPPARGTSHRDHODHHMGCR | |
| SCHEMBL22823977 | 0.85 | HMGCR (0.35) | PPARAPPARGTSHRDHODHHMGCR | |
| SCHEMBL29602246 | 0.81 | TSHR (0.33) | PPARAPPARGTSHRDHODHHMGCR | |
| SCHEMBL22823978 | 0.81 | TSHR (0.33) | PPARAPPARGTSHRDHODHHMGCR | |
| SCHEMBL29368033 | 0.81 | TSHR (0.33) | PPARAPPARGTSHRDHODHHMGCR | |
| SCHEMBL31324215 | 0.80 | KMO (0.32) | CYP2D6SLC6A2SLC6A4NOS2KMO | |
| SCHEMBL22823975 | 0.78 | PPARA (0.37) | PPARAPPARG | |
| SCHEMBL29369333 | 0.78 | PPARA (0.37) | PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114008012-B | Compounds for the treatment of neuromuscular disorders | NMD制药股份公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-114008012-A | Compounds for the treatment of neuromuscular disorders | NMD制药股份公司 | 2022-02-01 | — | — | CN | disclosed |